An **Autism Screening Test Package** is a comprehensive diagnostic evaluation designed to identify developmental delays and behavioral traits associated with Autism Spectrum Disorder (ASD). Tailored for children, adolescents, or adults, this multi-disciplinary package typically combines standardized clinical screening tools, behavioral observations, developmental history assessments, and cognitive or communication evaluations.
By gathering structured insights from specialists—such as developmental pediatricians, psychologists, and speech therapists—the panel helps clarify social interaction patterns, sensory sensitivities, and repetitive behaviors. Early detection through a formal test package empowers families to access tailored therapies, educational support, and interventions during critical developmental windows.

The **Array Chrome test** (Chromosomal Microarray Analysis / Array CGH) is an advanced genetic diagnostic test used primarily to evaluate pediatric health and developmental conditions. By scanning an individual's entire genome sequence at high resolution, it identifies tiny, sub-microscopic chromosomal abnormalities—specifically copy number variations (CNVs) like microdeletions or microduplications of DNA—that traditional karyotyping misses.
Healthcare providers commonly order this blood test for children displaying developmental delays, intellectual disabilities, autism spectrum disorders, unexplained seizures, or congenital malformations. Identifying these subtle genetic changes helps clinicians pinpoint underlying medical causes, tailor personalized treatment plans, and provide informed genetic counseling to families.